These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32370197)

  • 1. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
    Wu CY; Chan CH; Dubey NK; Wei HJ; Lu JH; Chang CC; Cheng HC; Ou KL; Deng WP
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21
    Milewski D; Pradhan A; Wang X; Cai Y; Le T; Turpin B; Kalinichenko VV; Kalin TV
    Oncogene; 2017 Feb; 36(6):850-862. PubMed ID: 27425595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK; Lee JS; Sukumar S
    Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
    Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
    Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.
    Zhao J; Xue X; Fu W; Dai L; Jiang Z; Zhong S; Deng B; Yin J
    Int J Oncol; 2020 May; 56(5):1083-1092. PubMed ID: 32319573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells.
    Wang Y; Wang H; Pan T; Li L; Li J; Yang H
    Oncotarget; 2016 Sep; 7(39):64360-64370. PubMed ID: 27608840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
    Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
    Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
    Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIST1H3D: A promising therapeutic target for lung cancer.
    Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
    Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression.
    Sun Y; Yang C; Chen J; Song X; Li Z; Duan M; Li J; Hu X; Wu K; Yan G; Yang C; Liu J; Tan W; Ye M
    J Cell Mol Med; 2016 Apr; 20(4):698-709. PubMed ID: 26849396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
    Andries V; Vandepoele K; Staes K; Berx G; Bogaert P; Van Isterdael G; Ginneberge D; Parthoens E; Vandenbussche J; Gevaert K; van Roy F
    BMC Cancer; 2015 May; 15():391. PubMed ID: 25958384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BARX1 repressed FOXF1 expression and activated Wnt/β-catenin signaling pathway to drive lung adenocarcinoma.
    Guan X; Liang J; Xiang Y; Li T; Zhong X
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129717. PubMed ID: 38290639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4.
    Bian F; Goda C; Wang G; Lan YW; Deng Z; Gao W; Acharya A; Reza AA; Gomez-Arroyo J; Merjaneh N; Ren X; Goveia J; Carmeliet P; Kalinichenko VV; Kalin TV
    EMBO Mol Med; 2024 May; 16(5):1063-1090. PubMed ID: 38589650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterolactone Induces G
    Chikara S; Lindsey K; Dhillon H; Mamidi S; Kittilson J; Christofidou-Solomidou M; Reindl KM
    Nutr Cancer; 2017; 69(4):652-662. PubMed ID: 28323486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells.
    Wei HJ; Nickoloff JA; Chen WH; Liu HY; Lo WC; Chang YT; Yang PC; Wu CW; Williams DF; Gelovani JG; Deng WP
    Oncotarget; 2014 Oct; 5(19):9514-29. PubMed ID: 25237908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.